| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/15/2000 | US6025391 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/15/2000 | US6025389 A mineral oil, one or more fatty alcohols or fatty esters, a polyoxyethylene ether or ester surfactant, xanthan gum, water and a method for treating a bacterial infection using said composition. |
| 02/15/2000 | US6025350 C-4" substituted macrolide antibiotics |
| 02/15/2000 | US6025349 Phenyl.-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 02/15/2000 | US6025343 Lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 02/15/2000 | US6025335 L-deoxyribofuranosyl nucleoside phosphodiester dimers where the sugar moiety or at least one of the nucleosides has an l-configuration, cancer and viral infections, in mammals. |
| 02/15/2000 | US6025182 Method for producing a virus from an african green monkey kidney cell line |
| 02/15/2000 | US6025164 Bacterial antigens and vaccine compositions |
| 02/15/2000 | US6025163 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 02/15/2000 | US6025156 Amino acid sequence; for discovery of antibiotics, bactericides, bacteristats against staphylococcus infections |
| 02/15/2000 | US6024979 Treatment of infections in ruminants with bolus |
| 02/15/2000 | US6024965 Immunology for treatment of aids and t-cell epitopes |
| 02/15/2000 | US6024962 Mercaptan gene and amine terminus with amine acid nucleic acid sequence |
| 02/15/2000 | US6024961 Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
| 02/15/2000 | CA2197739C 1,4-dihydropyridine compounds |
| 02/15/2000 | CA2015994C Human lactoferrin cdna sequence |
| 02/15/2000 | CA2006008C Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 02/10/2000 | WO2000006764A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | WO2000006745A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/10/2000 | WO2000006744A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006738A2 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/10/2000 | WO2000006737A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 02/10/2000 | WO2000006736A2 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006599A1 Inhibitors of hiv membrane fusion |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 02/10/2000 | WO2000006581A1 Novel carbapenem derivatives |
| 02/10/2000 | WO2000006577A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF |
| 02/10/2000 | WO2000006574A1 NOVEL C-2 S/O- AND S/N FORMALDEHYDE ACETAL DERIVATIVES OF CARBAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS ANTIBIOTICS AND β-LACTAMASE INHIBITORS |
| 02/10/2000 | WO2000006573A1 Antiviral alkyl substituted purine derivatives and their preparation |
| 02/10/2000 | WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | WO2000006205A1 Regulated expression of recombinant proteins using rna viruses |
| 02/10/2000 | WO2000006204A2 Genetically engineered cells and tissues |
| 02/10/2000 | WO2000006202A1 Virucide drug containing iodine |
| 02/10/2000 | WO2000006197A1 Combined vaccine for immunoprophylaxis against viral hepatitis b and d, tetanus and diphtheria |
| 02/10/2000 | WO2000006196A2 Multivalent human-bovine rotavirus vaccine |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006182A1 Use of extracts from aristolochia in the treatment of aids |
| 02/10/2000 | WO2000006181A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 02/10/2000 | WO2000006169A1 Integrin receptor antagonists |
| 02/10/2000 | WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | WO2000006123A1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 02/10/2000 | WO2000006120A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 02/10/2000 | WO2000006085A2 Compounds and methods |
| 02/10/2000 | WO2000006074A1 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions |
| 02/10/2000 | WO1999067254A3 Multi-drug resistant retroviral protease inhibitors and use thereof |
| 02/10/2000 | WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/10/2000 | WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | CA2340855A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2338816A1 Novel carbapenem derivatives |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | CA2338275A1 Integrin receptor antagonists |
| 02/10/2000 | CA2338022A1 Inhibitors of hiv membrane fusion |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2338001A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | CA2337102A1 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | CA2337092A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336875A1 Multivalent human-bovine rotavirus vaccine |
| 02/10/2000 | CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | CA2333854A1 Stereoisomers of cpg oligonucleotides and related methods |
| 02/10/2000 | CA2306010A1 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions |
| 02/10/2000 | CA2304596A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 02/09/2000 | EP0978289A1 Virucide drug containing iodine |
| 02/09/2000 | EP0978286A1 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 02/09/2000 | EP0978276A2 Polymer coated tablet comprising amoxycillin and clavunalate |
| 02/09/2000 | EP0977881A1 Expression of a modified foamy virus envelope protein |
| 02/09/2000 | EP0977874A1 Attenuated salmonella strain used as a vehicle for oral immunization |
| 02/09/2000 | EP0977862A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/09/2000 | EP0977852A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/09/2000 | EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 02/09/2000 | EP0977832A1 Method for inactivating a virus |
| 02/09/2000 | EP0977774A1 Antipathogenic synthetic peptides and compositions comprising them |
| 02/09/2000 | EP0977764A1 Method for generating saccharide fragments |
| 02/09/2000 | EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/09/2000 | EP0977591A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 02/09/2000 | EP0977590A1 Human monoclonal antibodies |
| 02/09/2000 | EP0977589A1 Adjuvant compositions for vaccines |
| 02/09/2000 | EP0977588A2 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 02/09/2000 | EP0977587A1 Chimeric flavivirus vaccines |